{"symbol": "KIN", "companyName": "Kindred Biosciences Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.kindredbio.com", "description": "Kindred Biosciences Inc is a development-stage biopharmaceutical company. It is engaged in saving and improving the lives of pets. The Company's product candidates are SentiKind, KIND-010 and KIND-012.", "CEO": "Richard Chin", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}